These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8646703)

  • 1. Looking forward in diagnostic pathology: the molecular superhighway.
    Abati A; Liotta LA
    Cancer; 1996 Jul; 78(1):1-3. PubMed ID: 8646703
    [No Abstract]   [Full Text] [Related]  

  • 2. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
    Seiden M; Sklar JL
    Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimal residual disease, the rationale for adjuvant therapy in epithelial malignancies.
    Nissan A
    J Surg Oncol; 2007 Sep; 96(3):185-7. PubMed ID: 17443732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
    Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular diagnostics of malignant melanoma: molecular staging, minimal residual disease].
    Tímár J; Csuka O
    Magy Onkol; 2003; 47(1):63-6. PubMed ID: 12704457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.
    Ghossein RA; Rosai J
    Cancer; 1996 Jul; 78(1):10-6. PubMed ID: 8646704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection, clinical relevance and specific biological properties of disseminating tumour cells.
    Pantel K; Brakenhoff RH; Brandt B
    Nat Rev Cancer; 2008 May; 8(5):329-40. PubMed ID: 18404148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
    von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
    Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation].
    Hokland P; Nyvold CG; Stentoft J; Ommen HB; Ebbesen LH; Braendstrup K; Andersen BL; Mikkelsen LS; Ostergaard M
    Ugeskr Laeger; 2009 Jan; 171(4):229-31. PubMed ID: 19174037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.
    Pfitzner T; Reiser M; Barth S; Borchmann P; Schulz H; Schinköthe T; Oberhäuser F; Wessels J; Tur M; Diehl V; Engert A
    Ann Hematol; 2002 May; 81(5):258-66. PubMed ID: 12029535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of recurrent translocations using real time PCR; assessment of the technique for diagnosis and detection of minimal residual disease.
    Gabert J
    Haematologica; 1999 Jun; 84 Suppl EHA-4():107-9. PubMed ID: 10907485
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterisation of minimal residual disease in solid tumors.
    Pantel K; Otte M
    Acta Med Austriaca Suppl; 2000; 52():8-12. PubMed ID: 11261279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymerase chain reaction in the detection of micrometastases and circulating tumor cells: present status and future potential.
    Ghossein RA; Rosai J
    Anat Pathol; 1998; 3():233-51. PubMed ID: 10389588
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring minimal residual disease in pediatric hematologic malignancies.
    Campana D
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):876-7, 915. PubMed ID: 18185484
    [No Abstract]   [Full Text] [Related]  

  • 17. Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.
    Fenk R; Ak M; Kobbe G; Steidl U; Arnold C; Korthals M; Hünerlitürkoglu A; Rohr UP; Kliszewski S; Bernhardt A; Haas R; Kronenwett R
    Haematologica; 2004 May; 89(5):557-66. PubMed ID: 15136219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of chromosome translocation t(9;22) using RT-PCR].
    Sidorova ZhI; Bogdanov KV; Kapustin SI; Lyshchev AA; Marinets OV; Ogorodnikova IuS; Martynkevich IS; Sitskaia KO; Zubarovskaia LS; Zaritskiĭ AIu; Afanas'ev BV; Abdulkadyrov KM; Blinov MN
    Vopr Onkol; 1998; 44(3):300-3. PubMed ID: 9695776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and clinical significance of occult tumour cells in colorectal cancer.
    Tsavellas G; Patel H; Allen-Mersh TG
    Br J Surg; 2001 Oct; 88(10):1307-20. PubMed ID: 11578283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
    Köstler WJ; Brodowicz T; Hejna M; Wiltschke C; Zielinski CC
    Cancer Detect Prev; 2000; 24(4):376-403. PubMed ID: 11059569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.